전체 글

신장병과 함께 살아가는 모든 면을 탐색합니다

태그Causes of CKD초기화5개 일치
Polycystic Kidney Disease (ADPKD): Inheritance, Predicting How Fast It Progresses, the Science Behind Tolvaptan and 3 Litres of Water a Day, Family Screening, and Whether to Remove the Kidneys Before Transplant
만성콩팥병 12 분 소요

Polycystic Kidney Disease (ADPKD): Inheritance, Predicting How Fast It Progresses, the Science Behind Tolvaptan and 3 Litres of Water a Day, Family Screening, and Whether to Remove the Kidneys Before Transplant

ADPKD is the most common inherited kidney disease — about 1 in 1,000 people carry the gene and it accounts for 5–10% of the world's dialysis population. PKD1 vs PKD2, how the Mayo imaging class predicts the age of kidney failure, tolvaptan (the only approved disease-slowing drug), the evidence for water and salt, brain aneurysm screening, whether children should be tested, and how huge kidneys are handled on dialysis and at transplant.

더 읽기
Lupus and the Kidney: The Six Classes of Lupus Nephritis, the 2024 Treatment Shift (belimumab, voclosporin, obinutuzumab), and When Dialysis or Transplant Comes In
만성콩팥병 12 분 소요

Lupus and the Kidney: The Six Classes of Lupus Nephritis, the 2024 Treatment Shift (belimumab, voclosporin, obinutuzumab), and When Dialysis or Transplant Comes In

About 40–60% of people with systemic lupus erythematosus develop lupus nephritis, a leading cause of kidney failure in young women. Why a biopsy is essential, what the six classes mean, the move to low-dose steroids and triple therapy, and what is different for lupus patients on dialysis or waiting for a transplant.

더 읽기
Diabetes and Kidney Disease: Why It Is the No. 1 Cause of Dialysis, How to Screen, and Which New Drugs Protect the Kidneys (2026 Guide)
만성콩팥병 13 분 소요

Diabetes and Kidney Disease: Why It Is the No. 1 Cause of Dialysis, How to Screen, and Which New Drugs Protect the Kidneys (2026 Guide)

Nearly half of new dialysis patients in Taiwan start because of diabetes. A plain-language guide to how high glucose damages the kidney, the two tests to do every year, glucose and blood-pressure targets, the three kidney-protective drug classes (SGLT2 inhibitors, GLP-1 RAs, finerenone), and what changes once you are on dialysis or transplanted.

더 읽기